NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 1109 coverAutoimmunity, Part A Basic Principles and New Diagnostic Tools Volume 1109 published September 2007
Ann. N.Y. Acad. Sci. 1109: 221–228 (2007). doi: 10.1196/annals.1398.026
Copyright © 2007 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via Google Scholar
Google Scholar
Articles by TAMBY, M. C.
Articles by MOUTHON, L.
Search for Related Content
PubMed
PubMed Citation
Articles by TAMBY, M. C.
Articles by MOUTHON, L.

Part II. New Tools in Diagnosis

Antitopoisomerase 1 Antibodies in Systemic Sclerosis

How to Improve the Detection?

MATHIEU C. TAMBYa, GUILLAUME BUSSONEa,b AND LUC MOUTHONa,b

a Paris Descartes University, Faculty of Medicine, UPRES EA 4058 Site Cochin, Paris, France b Paris Descartes University, Faculty of Medicine, Internal Medicine Department and French National Reference Center for Systemic Sclerosis and Necrotizing Vasculitides, Cochin Hospital, Assistance Publique–Hôpitaux de Paris, Paris, France

Key Words: antitopoisomerase 1 antibodies • systemic sclerosis • immunoblot • ELISA • double immunodiffusion

Address for correspondence: Dr. Luc Mouthon, UPRES EA 4058, Pavillon Gustave Roussy, 4e étage, Université Paris Descartes, 8 rue Méchain, 75014, Paris, France. Voice: +33-0-144412544; fax: +33-0-144412546.  luc.mouthon{at}cch.aphp.fr

Among the multiple autoantibodies identified in the serum of systemic sclerosis (SSc) patients, three are disease-specific, mutually exclusive, and helpful to determine the prognosis: anticentromere antibodies, antitopoisomerase 1 antibodies (ATA), and anti-RNA-polymerase III antibodies. ATA can be identified through different techniques, including double immunodiffusion (DID) assay, enzyme-linked immunosorbent assay (ELISA), or immunoblot. Although all of them are commonly used, none of them can be considered as the reference. Herein, we propose a brief description of the different methods available for the detection of ATA. All these studies revealed that ATA, determined by DID assay, ELISA, or immunoblot, are highly specific for SSc although the reported sensitivity is fickle. As we recently reported, patients with ATA had an almost similar phenotype without distinction between the methods of detection, ELISA, and immunoblot, and the use of these two techniques improves the sensitivity without diminishing the specificity. Thus, we may propose that a combination of the immunoblot using HEp-2 cells antigens and ELISA could be used for the detection of ATA.






footerLeft footerRight